NCT02318069View on ClinicalTrials.gov

New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

June 30, 2017

Conditions
Tick-borne Encephalitis
Interventions
BIOLOGICAL

FSME-immune

0.5 ml im as scheduled in the 5 arms

Trial Locations (2)

00029

Dept infectious diseases, Helsinki

631 88

Dept infectious diseases, Eskilstuna

All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

collaborator

Helsingfors university

UNKNOWN

lead

Sormland County Council, Sweden

OTHER

NCT02318069 - New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly | Biotech Hunter | Biotech Hunter